Lion Biotechnologies Inc (LBIO)

7.95
0.05 0.62
NASDAQ : Health Care
Prev Close 8.00
Open 8.05
Day Low/High 7.70 / 8.05
52 Wk Low/High 4.45 / 8.60
Volume 347.20K
Avg Volume 427.00K
Exchange NASDAQ
Shares Outstanding 62.35M
Market Cap 433.34M
EPS -3.50
P/E Ratio N/A
Div & Yield N.A. (N.A)
RSI Alert: Lion Biotechnologies (LBIO) Now Oversold

RSI Alert: Lion Biotechnologies (LBIO) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

5 Health Care Stocks Under $10 Set to Soar

5 Health Care Stocks Under $10 Set to Soar

These under-$10 stocks look ready to break out and trade higher from current levels.

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Cramer sees a week bookended by Greece and the monthly jobs report, with many company earnings for good measure.

First Week of August 21st Options Trading For Lion Biotechnologies (LBIO)

First Week of August 21st Options Trading For Lion Biotechnologies (LBIO)

Investors in Lion Biotechnologies Inc saw new options become available this week, for the August 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the LBIO options chain for the new August 21st contracts and identified the following put contract of particular interest.

Lion Biotechnologies Becomes Oversold (LBIO)

Lion Biotechnologies Becomes Oversold (LBIO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Stock Index Tracking Red-Hot Cancer Immunotherapy Field Launched

Stock Index Tracking Red-Hot Cancer Immunotherapy Field Launched

The Loncar Cancer Immunotherapy Index (LCINDX) tracks biopharma companies developing (or already marketing) drugs which use the body's own immune system to target and kill cancer cells.

'Mad Money' Lightning Round: I'm Staying Away From Five Below

'Mad Money' Lightning Round: I'm Staying Away From Five Below

Cramer isn't crazy about Dicerna Pharmaceuticals and Ziopharm Oncology but he likes Akamai and Lion Biotechnologies.

Jim Cramer's 'Mad Money' Recap: The Fed Does the Right Thing

Jim Cramer's 'Mad Money' Recap: The Fed Does the Right Thing

The Federal Reserve is smarter than you think, Cramer says.

Lion Biotechnologies Obtains Exclusive License From NIH For Next-Generation TIL Technology

Lion Biotechnologies Obtains Exclusive License From NIH For Next-Generation TIL Technology

Novel Method Enhances Quality and Efficiency of TIL Production

Lion Biotechnologies CSO Laszlo Radvanyi Co-authors Study In Clinical Cancer Research

Lion Biotechnologies CSO Laszlo Radvanyi Co-authors Study In Clinical Cancer Research

Research Validates Method for Enhancing Quality and Efficiency of TIL Production